myirislogo
25 November, 2014 02:43 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 308.50 1.13
Hindalco In 165.55 3.37
Tata Stl 476.60 3.00
Tata Power 91.75 4.14
Tata Motors 526.60 0.73
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Natco Pharma Limited
Natco Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524816NSE:NATCOPHARMBloomberg:NTCPH@INReuters:NATP.BO
Market Lot: 1Face Value: 10ISIN Demat: INE987B01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
21-OCT-14 Natco Pharma, one of the few Indian companies to venture into new drug discovery research, announced that its marketing partner in the USA, Breckenridge Pharmaceutical has received a tentative approval from the United States Food & Drug Administration (USFDA) for Armodafinil 50mg, 150mg and 250mg tablets. 18-SEP-14 Natco Pharma, one of the few Indian companies to venture into new drug discovery research, has made proposed commitments...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Natco Pharma jumps after getting USFDA nod for Armodafinil tablets  -IRIS 21-Oct-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1620.005720.405143.30
Other Income8.80157.10119.40
Total Income1628.805877.505262.70
Cost of goods sold1209.204357.504023.30
OPBDIT419.601520.001239.40
PAT364.101101.90781.30
Gross Block---
Equity capital330.70330.70313.70
EPS (Rs.)-34.4924.91
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.31 - 25.4313.25 - 20.28
Debt / Equity (x)---
Operating margin (% of OI)25.825.923.6
Net margin (% of OI)22.418.714.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Natco House
Road No 2
Banjara Hills
Hyderabad
Andhra Pradesh-500 033
PHONE
(040) 2354 7532
FAX
(040) 2354 8243
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer